# SOLA Pharmaceuticals LLC – FDA Inspection, Mar 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/sola-pharmaceuticals-llc/6de6f651-d0cb-4816-9be3-c15168a5fb24
Source feed: FDA_Inspections

> FDA inspection 1088275 of SOLA Pharmaceuticals LLC, March 22, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1088275
- Company Name: SOLA Pharmaceuticals LLC
- Inspection Date: 2019-03-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1258442 - 2025-01-08
- [FDA Inspection 1256965 - 2024-12-18](https://www.keypedia.com/records/fda_inspections/sola-pharmaceuticals-llc/c213fd93-f106-499a-806f-ef3b23614b3d)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/francis-a-guidry/fd6d2a17-7f94-4f7c-8284-ad1f07d703e9)

Company: https://www.keypedia.com/companies/sola-pharmaceuticals-llc/d3c93547-0516-49be-b228-d37582081dbb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
